With the moratorium on publishing audited preliminary results in place, EKF has instead provided a comprehensive trading update with headline FY19 financials and an update on the outlook, including regarding the potential impact of Covid-19. In short, no impact has been seen to date and, whilst ordering patterns may experience some short term disruption, the testing of vulnerable groups such as Diabetes and Anaemia patients is more important than ever. Added to that, EKF has recently entered
24 Mar 2020
Robust model proving its mettle
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Robust model proving its mettle
EKF Diagnostics Holdings plc (EKF:LON) | 28.0 0 0.0% | Mkt Cap: 127.0m
- Published:
24 Mar 2020 -
Author:
Chris Glasper -
Pages:
4
With the moratorium on publishing audited preliminary results in place, EKF has instead provided a comprehensive trading update with headline FY19 financials and an update on the outlook, including regarding the potential impact of Covid-19. In short, no impact has been seen to date and, whilst ordering patterns may experience some short term disruption, the testing of vulnerable groups such as Diabetes and Anaemia patients is more important than ever. Added to that, EKF has recently entered